Back
Lam Research 10K Form
Sell
39
LRCX
Lam Research
Last Price:
73.02
Seasonality Move:
16.71%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-29 | 10Q | LRCX/Lam Research Quarterly |
| 2024-01-29 | 10Q | LRCX/Lam Research Quarterly |
| 2023-10-23 | 10Q | LRCX/Lam Research Quarterly |
| 2023-08-15 | 10K | LRCX/Lam Research Annual |
| 2023-04-24 | 10Q | LRCX/Lam Research Quarterly |
| 2023-01-30 | 10Q | LRCX/Lam Research Quarterly |
Receive LRCX News And Ratings
See the #1 stock for the next 7 days that we like better than LRCX
LRCX Financial Statistics
Sales & Book Value
| Annual Sales: | $14.91B |
|---|---|
| Cash Flow: | $1.46B |
| Price / Cash Flow: | 19.15 |
| Annual Sales: | $6.56 |
| Price / Book: | 10.72 |
Profitability
| EPS (TTM): | 3.09400 |
|---|---|
| Net Income (TTM): | $4.06B |
| Gross Margin: | $7.05B |
| Return on Equity: | 49.11% |
| Return on Assets: | 21.61% |
Lam Research Earnings Forecast
Key Lam Research Financial Ratios
- The Gross Profit Margin over the past 41 years for LRCX is 47.32%.
- The Selling, General & Administrative Expenses for LRCX have been equal to 5.83% of Gross Profit Margin.
- The Research & Development expenses have been 12.76% of Revenue.
- The Interest Expense is 4.84% of Operating Income.
- The Net Earning history of LRCX is 25.68% of Total Revenues.
- Per Share Earnings over the last 41 years have been positive in 28 years.
Lam Research Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Semiconductors & Semiconductor Equipment |
| Sector: | Information Technology |
| Current Symbol: | LRCX |
| CUSIP: | 512807 |
| Website: | lamresearch.com |
Debt
| Debt-to-Equity Ratio: | 0.59 |
|---|---|
| Current Ratio: | 2.53 |
| Quick Ratio: | 1.69 |
Price-to-Earnings
| Trailing P/E Ratio: | 24.33 |
|---|---|
| Forward P/E Ratio: | 16.7 |
LRCX Technical Analysis vs Fundamental Analysis
Sell
39
Lam Research (LRCX)
is a Sell
Is Lam Research a Buy or a Sell?
-
Lam Research stock is rated a Sell
The current Lam Research [LRCX] share price is $70.05. The Score for LRCX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.